Hao J. Wu - Publications

Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: September 20, 2017

Human induced pluripotent stem cell-derived mesenchymal stem cells prevent adriamycin nephropathy in mice.

Journal: Oncotarget

Published: March 06, 2017

N-acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice.

Journal: Nephrology (Carlton, Vic.)

Published: August 21, 2016

Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress.

Journal: Kidney international

Published: April 14, 2015

N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice.

Journal: Mediators of inflammation

Published: April 08, 2015

BMP7 reduces inflammation and oxidative stress in diabetic tubulopathy.

Journal: Clinical science (London, England : 1979)

Published: September 10, 2014

Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis.

Journal: PloS one

Published: November 08, 2013

The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.

Journal: Kidney international

Published: February 21, 2013

Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.

Journal: Journal of the American Society of Nephrology : JASN

Published: October 25, 2011